Literature DB >> 8440418

Reversibility of hepatopulmonary syndrome evidenced by serial pulmonary perfusion scan.

H Shijo1, H Sasaki, H Sakata, H Kusuhara, T Ueki, M Okumura.   

Abstract

A patient with liver cirrhosis who exhibited marked hypoxemia is presented. An abnormal dilatation of intrapulmonary capillaries was evidenced by perfusion lung scan, contrast-enhanced echocardiography, and histological examinations of lungs. Serial perfusion lung scan disclosed that the radioisotope uptake by extrapulmonary organs was significantly increased and uptake by both lungs was significantly decreased during the state of severer hypoxemia. Shunt quantification method revealed that intrapulmonary right-to-left shunt ratio also paralleled the extent of hypoxemia. The pathophysiology of hepatopulmonary syndrome appeared to involve a reversible intrapulmonary vascular dilatation. The perfusion lung scan could semiquantitate the severity of intrapulmonary vascular dilatation and could offer the efficient method to follow their progress.

Entities:  

Mesh:

Year:  1993        PMID: 8440418     DOI: 10.1007/bf02775013

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  19 in total

Review 1.  Hepatopulmonary syndrome: an evolving perspective in the era of liver transplantation.

Authors:  M J Krowka; D A Cortese
Journal:  Hepatology       Date:  1990-01       Impact factor: 17.425

2.  Anomogram for venous shunt (Qs-Qt) calculation.

Authors:  S T Chiang
Journal:  Thorax       Date:  1968-09       Impact factor: 9.139

3.  Detection of pulmonary telangiectasia using dynamic pulmonary perfusion imaging in patients with liver cirrhosis.

Authors:  H Shijo; S Hisano; H Sasaki; K Yuh; H Kusuhara; S Sakaguchi; M Okumura; H Sakata
Journal:  Clin Nucl Med       Date:  1989-03       Impact factor: 7.794

4.  Renal prostaglandin E2 and other vasoactive modulators in refractory hepatic ascites: response to peritoneovenous shunting.

Authors:  T Shaw-Stiffel; P J Campbell; M J Sole; P Greig; P Y Wong; L M Blendis
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

Review 5.  The lung in patients with cirrhosis.

Authors:  A G Agustí; J Roca; J Bosch; R Rodriguez-Roisin
Journal:  J Hepatol       Date:  1990-03       Impact factor: 25.083

6.  Reversibility of pulmonary telangiectasia in liver cirrhosis evidenced by serial dynamic pulmonary perfusion imaging.

Authors:  H Shijo; K Nakayama; H Sasaki; T Ueki; S Sakaguchi; H Sakata; M Okumura
Journal:  Clin Nucl Med       Date:  1989-12       Impact factor: 7.794

7.  Severe hypoxemia and liver disease.

Authors:  E S Edell; D A Cortese; M J Krowka; K Rehder
Journal:  Am Rev Respir Dis       Date:  1989-12

8.  Severe hypoxemia associated with liver disease: Mayo Clinic experience and the experimental use of almitrine bismesylate.

Authors:  M J Krowka; D A Cortese
Journal:  Mayo Clin Proc       Date:  1987-03       Impact factor: 7.616

9.  Alveolar-capillary oxygen disequilibrium in hepatic cirrhosis.

Authors:  H H Davis; D J Schwartz; S S Lefrak; N Susman; B A Schainker
Journal:  Chest       Date:  1978-04       Impact factor: 9.410

Review 10.  Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis.

Authors:  V Arroyo; P Ginés; A Rimola; J Gaya
Journal:  Am J Med       Date:  1986-08-25       Impact factor: 4.965

View more
  3 in total

1.  The role of garlic in hepatopulmonary syndrome: a randomized controlled trial.

Authors:  Binay K De; Deep Dutta; Subrata K Pal; Subhabrata Gangopadhyay; Sumanta Das Baksi; Adyapad Pani
Journal:  Can J Gastroenterol       Date:  2010-03       Impact factor: 3.522

2.  Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation. The Cleveland Clinic experience.

Authors:  J K Stoller; P A Lange; M K Westveer; W D Carey; D Vogt; J M Henderson
Journal:  West J Med       Date:  1995-08

3.  Evolution of gas exchange abnormalities in patients with liver cirrhosis candidate for liver transplantation.

Authors:  S M A Ghayumi; S Mehrabi; M Hoseini Asl
Journal:  Iran Red Crescent Med J       Date:  2012-03-01       Impact factor: 0.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.